Cvs Health (CVS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $92.58, +2.42% vs the prior close of $90.39.
- Volume 14.26M shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CVS rises 2.4% to $92.58, a 1-month high. Closed at $92.58, +2.42% vs the prior close of $90.39. Day range $91.00–$92.64, opened at $91.78.
CVS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CVS rises 2.4% to $92.58, a 1-month high
- Closed at $92.58, +2.42% vs the prior close of $90.39. Day range $91.00–$92.64, opened at $91.78.
- Volume was 14.26M shares, 1.7x its 50-day average of 8.24M.
- Price is +0.8% vs its 50-day average ($91.80) and +5.1% vs its 200-day average ($88.12).
- 52-week range $69.51–$110.68; today's close sits at 56% of that range, 16.4% below the 52-week high.
Oct 14, 2026 — CVS jumps 3.2% to $90.39
- Closed at $90.39, +3.24% vs the prior close of $87.55. Day range $88.10–$90.78, opened at $88.10.
- Volume was 9.33M shares, 1.1x its 50-day average of 8.20M.
- Price is -1.7% vs its 50-day average ($91.93) and +2.7% vs its 200-day average ($88.06).
- 52-week range $69.51–$110.68; today's close sits at 51% of that range, 18.3% below the 52-week high.
Oct 13, 2026 — CVS ends flat (-0.2%) to $87.55
- Closed at $87.55, -0.22% vs the prior close of $87.74. Day range $86.13–$89.89, opened at $89.20.
- Volume was 10.48M shares, 1.3x its 50-day average of 8.09M.
- Price is -5.1% vs its 50-day average ($92.21) and -0.5% vs its 200-day average ($88.00).
- 52-week range $69.51–$110.68; today's close sits at 44% of that range, 20.9% below the 52-week high.
Oct 12, 2026 — CVS rises 1.8% to $87.74
- Closed at $87.74, +1.83% vs the prior close of $86.16. Day range $86.05–$87.98, opened at $86.60.
- Volume was 11.57M shares, 1.4x its 50-day average of 8.00M.
- Price is -5.2% vs its 50-day average ($92.57) and -0.3% vs its 200-day average ($87.96).
- 52-week range $69.51–$110.68; today's close sits at 44% of that range, 20.7% below the 52-week high.
Oct 9, 2026 — CVS dips 1.9% to $86.16
- Closed at $86.16, -1.87% vs the prior close of $87.80. Day range $85.80–$88.86, opened at $85.90.
- Volume was 11.65M shares, 1.5x its 50-day average of 7.93M.
- Price is -7.3% vs its 50-day average ($92.90) and -2.0% vs its 200-day average ($87.91).
- 52-week range $69.51–$110.68; today's close sits at 40% of that range, 22.2% below the 52-week high.
Oct 8, 2026 — CVS ends flat (-0.2%) to $87.80
- Closed at $87.80, -0.17% vs the prior close of $87.95. Day range $86.82–$88.50, opened at $87.86.
- Volume was 7.83M shares, 1.0x its 50-day average of 7.92M.
- Price is -5.9% vs its 50-day average ($93.28) and -0.1% vs its 200-day average ($87.87).
- 52-week range $69.51–$110.68; today's close sits at 44% of that range, 20.7% below the 52-week high.
Oct 7, 2026 — CVS rises 1.8% to $87.95
- Closed at $87.95, +1.76% vs the prior close of $86.43. Day range $87.00–$89.93, opened at $87.05.
- Volume was 8.47M shares, 1.1x its 50-day average of 7.89M.
- Price is -6.1% vs its 50-day average ($93.65) and +0.1% vs its 200-day average ($87.82).
- 52-week range $69.51–$110.68; today's close sits at 45% of that range, 20.5% below the 52-week high.
Oct 6, 2026 — CVS dips 0.7% to $86.43
- Closed at $86.43, -0.67% vs the prior close of $87.01. Day range $85.53–$87.08, opened at $86.80.
- Volume was 11.04M shares, 1.4x its 50-day average of 7.82M.
- Price is -8.1% vs its 50-day average ($94.08) and -1.5% vs its 200-day average ($87.77).
- 52-week range $69.51–$110.68; today's close sits at 41% of that range, 21.9% below the 52-week high.
Oct 5, 2026 — CVS rises 0.6% to $87.01
- Closed at $87.01, +0.64% vs the prior close of $86.46. Day range $86.33–$87.51, opened at $86.69.
- Volume was 12.01M shares, 1.6x its 50-day average of 7.69M.
- Price is -7.9% vs its 50-day average ($94.49) and -0.8% vs its 200-day average ($87.73).
- 52-week range $69.51–$110.68; today's close sits at 43% of that range, 21.4% below the 52-week high.
Oct 2, 2026 — CVS rises 1.5% to $86.46
- Closed at $86.46, +1.48% vs the prior close of $85.20. Day range $85.25–$87.15, opened at $85.25.
- Volume was 10.46M shares, 1.4x its 50-day average of 7.60M.
- Price is -8.9% vs its 50-day average ($94.90) and -1.4% vs its 200-day average ($87.69).
- 52-week range $69.51–$110.68; today's close sits at 41% of that range, 21.9% below the 52-week high.
CVS latest news & SEC filings
Every SEC filing by or about CVS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 17, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 13F-HR — Quarterly holdings report filed by an institutional investment manager
Quarterly holdings report filed by an institutional investment manager
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $106.10B (prior year $98.92B) (+7.3% vs Jun 30, 2025)
- Net income: $2.98B (prior year $1.02B) (+191.8% vs Jun 30, 2025)
- Diluted EPS: $2.31 (prior year $0.80) (+188.8% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade CVS
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 10, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.47% (largest 4.8%).
- Liquidity: about 10.41M shares (≈$964.19M) trade per day on average.
- 52-week position: $92.58 vs a range of $69.51–$110.68 (56% of the range).
- Dividends: last ex-dividend date Jul 23, 2026 ($0.665/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Larry Robbins sold 370,462 shares on May 21, 2026.
- Latest filings: 8-K Aug 17, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 1.28B shares outstanding (Jul 29, 2026), +0.8% vs a year earlier.
- Listing: NYSE · industry: Retail-Drug Stores and Proprietary Stores.
CVS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 91.78 | 92.64 | 91.00 | 92.58 | 14.26M |
| Oct 14, 2026 | 88.10 | 90.78 | 88.10 | 90.39 | 9.33M |
| Oct 13, 2026 | 89.20 | 89.89 | 86.13 | 87.55 | 10.48M |
| Oct 12, 2026 | 86.60 | 87.98 | 86.05 | 87.74 | 11.57M |
| Oct 9, 2026 | 85.90 | 88.86 | 85.80 | 86.16 | 11.65M |
| Oct 8, 2026 | 87.86 | 88.50 | 86.82 | 87.80 | 7.83M |
| Oct 7, 2026 | 87.05 | 89.93 | 87.00 | 87.95 | 8.47M |
| Oct 6, 2026 | 86.80 | 87.08 | 85.53 | 86.43 | 11.04M |
| Oct 5, 2026 | 86.69 | 87.51 | 86.33 | 87.01 | 12.01M |
| Oct 2, 2026 | 85.25 | 87.15 | 85.25 | 86.46 | 10.46M |
| Oct 1, 2026 | 85.48 | 86.26 | 84.23 | 85.20 | 6.56M |
| Sep 30, 2026 | 87.04 | 87.44 | 85.42 | 85.69 | 8.38M |
| Sep 29, 2026 | 87.20 | 87.56 | 86.36 | 87.10 | 7.15M |
| Sep 28, 2026 | 89.51 | 90.02 | 87.83 | 87.85 | 7.90M |
| Sep 25, 2026 | 85.35 | 89.35 | 84.70 | 89.13 | 15.77M |
| Sep 24, 2026 | 85.83 | 86.01 | 84.50 | 85.05 | 7.38M |
| Sep 23, 2026 | 86.70 | 86.98 | 85.67 | 85.86 | 7.31M |
| Sep 22, 2026 | 87.69 | 88.28 | 86.68 | 87.10 | 8.71M |
| Sep 21, 2026 | 88.73 | 88.91 | 87.19 | 87.60 | 10.14M |
| Sep 18, 2026 | 90.09 | 90.48 | 88.15 | 88.84 | 21.88M |
About Cvs Health
Cvs Health (CVS) is listed on the NYSE and classified by the SEC under “Retail-Drug Stores and Proprietary Stores”. Its business address is in WOONSOCKET, RI. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 64803.
CVS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Fernando Aguirre | Director | May 22, 2026 |
| C David Ii Brown | Director | May 15, 2026 |
| Jeffrey R. Balser | Director | May 15, 2026 |
| Alecia A Decoudreaux | Director | May 15, 2026 |
| Roger N Farah | Director | Dec 2, 2025 |
| Anne A. Finucane | Director | May 15, 2026 |
| John E Gallina | Director | May 15, 2026 |
| J. David Joyner | President, CEO and Chair | Apr 2, 2026 |
| J Scott Kirby | Director | May 15, 2026 |
| Michael F Mahoney | Director | May 15, 2026 |
| Leslie V Norwalk | Director | May 15, 2026 |
| Larry Robbins | Director | May 21, 2026 |
| Guy P Sansone | Director | May 15, 2026 |
| Douglas H. Shulman | Director | May 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Heidi B Capozzi | EVP and Chief People Officer | Apr 2, 2026 |
| James David Clark | SVP, Cont & Chief Acct Officer | Jun 29, 2026 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | Jun 1, 2026 |
| J. David Joyner | President, CEO and Chair | Apr 2, 2026 |
| Samrat S. Khichi | EVP, CPO and General Counsel | Apr 2, 2026 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | May 11, 2026 |
| Steven H Nelson | EVP and President, Aetna | Apr 2, 2026 |
| Brian Newman | EVP, Chief Financial Officer | Jun 1, 2026 |
| Prem S Shah | EVP and Group President | Apr 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | Larry Robbins | Sale | 370,462 | $93.45 |
| May 20, 2026 | Larry Robbins | Sale | 66,881 | $95.67 |
| May 20, 2026 | Larry Robbins | Sale | 800 | $96.28 |
| May 20, 2026 | Larry Robbins | Sale | 797,628 | $93.48 |
| May 20, 2026 | Larry Robbins | Sale | 152,691 | $94.81 |
| May 19, 2026 | Larry Robbins | Sale | 1,983,387 | $94.45 |
| May 19, 2026 | Larry Robbins | Sale | 151 | $95.18 |
| May 8, 2026 | Tilak Mandadi | Sale | 69,551 | $89.58 |
| Jan 23, 2025 | Steven H Nelson | Buy | 24 | $53.70 |
| Oct 23, 2024 | Heidi B Capozzi | Buy | 35 | $56.85 |
| Oct 2, 2024 | Heidi B Capozzi | Buy | 10 | $62.24 |
| Sep 9, 2024 | Heidi B Capozzi | Buy | 35 | $56.47 |
CVS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $1.77B | — | $10.64B |
| Dec 31, 2024 | — | $4.61B | — | $9.11B |
| Dec 31, 2023 | — | $8.34B | — | $13.43B |
| Dec 31, 2022 | — | $4.31B | — | $16.18B |
| Dec 31, 2021 | — | $8.00B | — | $18.27B |
Latest balance sheet: total assets $253.77B, total liabilities $173.87B, cash $11.33B (as of Jun 30, 2026).
CVS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $99.12 |
| May 6, 2026 | 8-K Item 2.02 (results) | $86.86 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $75.70 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $80.60 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $62.10 |
| May 1, 2025 | 8-K Item 2.02 (results) | $69.45 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $63.22 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $61.61 |
| Oct 18, 2024 | 8-K Item 2.02 (results) | $60.34 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Retail-Drug Stores and Proprietary Stores
Guardian Pharmacy Services (GRDN)111 (YI)Petmed Express (PETS)Ridgetech (RDGT)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CVS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.